ipratroopiumbromiid
Ipratropium bromide is a synthetic quaternary ammonium derivative of atropine, primarily used as a medication to treat respiratory conditions. It functions as a muscarinic acetylcholine receptor antagonist, meaning it blocks the action of acetylcholine, a neurotransmitter that constricts smooth muscles, including those in the airways. By inhibiting these receptors, ipratropium bromide helps relax bronchial smooth muscle, thereby reducing bronchoconstriction and improving airflow in the lungs.
The compound was first synthesized in the 1960s and has since become a standard treatment for conditions
As an anticholinergic agent, ipratropium bromide is generally well-tolerated, though common side effects may include dry
The chemical structure of ipratropium bromide consists of a quaternary ammonium group, which prevents it from